RenaissanceRe Q4 Earnings Announcement Scheduled
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5d ago
0mins
Should l Buy RNR?
Source: seekingalpha
- Earnings Release Date: RenaissanceRe is set to announce its Q4 earnings on February 3rd after market close, with a consensus EPS estimate of $10.41, reflecting a 29.2% year-over-year growth, indicating sustained profitability.
- Revenue Expectations Decline: Despite the optimistic EPS outlook, the revenue estimate stands at $1.67 billion, representing a 27.1% year-over-year decline, highlighting potential challenges in the market environment and business fluctuations.
- Historical Performance: Over the past two years, RenaissanceRe has beaten EPS estimates 88% of the time and revenue estimates 63% of the time, demonstrating the company's reliability in earnings forecasts and market confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 14 upward revisions and 1 downward revision, while revenue estimates have had 1 upward revision with no downward adjustments, reflecting analysts' optimistic outlook on the company's future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RNR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RNR
Wall Street analysts forecast RNR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RNR is 308.36 USD with a low forecast of 267.00 USD and a high forecast of 455.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
3 Buy
7 Hold
1 Sell
Hold
Current: 305.290
Low
267.00
Averages
308.36
High
455.00
Current: 305.290
Low
267.00
Averages
308.36
High
455.00
About RNR
RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance, focused on aligning risk with capital. It offers property, casualty, and specialty reinsurance, along with certain insurance solutions, primarily through intermediaries. It has two reportable segments: Property and Casualty and Specialty. The Property segment includes catastrophe reinsurance, primarily excess of loss and retrocessional coverage for natural and man-made disasters, as well as other property business such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional multi-line business. The Casualty and Specialty segment encompasses reinsurance activities across a range of complex, longer-tail risk categories, including general casualty, professional liability, credit, and other specialty lines of reinsurance. The Company combines data, technology, and the ability to deliver risk solutions and capacity through owned and managed partner balance sheets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
RenaissanceRe Holdings (RNR.US) Officer Plans to Sell $4.43 Million in Common Stock via Form 144 Amendment
- Stock Sale Announcement: Officer Ross Curtis of Renaissance Re Holdings intends to sell 15,000 shares of its common stock.
- Market Value: The total market value of the shares being sold is approximately $4.43 million.
See More
RenaissanceRe Q4 Earnings Exceed Expectations
- Earnings Beat: RenaissanceRe reported a Q4 non-GAAP EPS of $13.34, surpassing expectations by $2.93, which reflects the company's strong profitability and boosts investor confidence.
- Significant Revenue Growth: The company achieved revenues of $2.97 billion in Q4, marking a 29.7% year-over-year increase and exceeding forecasts by $1.3 billion, indicating robust competitive positioning and business expansion capabilities.
- Undervalued Preferred Stocks: Market analysis suggests that RenaissanceRe's preferred stocks are undervalued, potentially offering investors a compelling opportunity, highlighting the company's advantages in capital structure.
- Positive Future Outlook: With ongoing growth in the insurance and reinsurance markets, analysts maintain an optimistic outlook for RenaissanceRe's future performance, which is expected to further enhance shareholder returns and market share.
See More
RenaissanceRe Q4 Earnings Announcement Scheduled
- Earnings Release Date: RenaissanceRe is set to announce its Q4 earnings on February 3rd after market close, with a consensus EPS estimate of $10.41, reflecting a 29.2% year-over-year growth, indicating sustained profitability.
- Revenue Expectations Decline: Despite the optimistic EPS outlook, the revenue estimate stands at $1.67 billion, representing a 27.1% year-over-year decline, highlighting potential challenges in the market environment and business fluctuations.
- Historical Performance: Over the past two years, RenaissanceRe has beaten EPS estimates 88% of the time and revenue estimates 63% of the time, demonstrating the company's reliability in earnings forecasts and market confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 14 upward revisions and 1 downward revision, while revenue estimates have had 1 upward revision with no downward adjustments, reflecting analysts' optimistic outlook on the company's future performance.
See More
RenaissanceRe, Phibro, and Commercial Metals Rated Strong with Notable Earnings Growth
- RenaissanceRe Earnings Surge: RenaissanceRe Holdings Ltd. has seen its current year earnings estimate rise by 27.4% over the last 60 days, indicating robust performance in the insurance and reinsurance sector, which is likely to drive stock price appreciation and bolster market confidence.
- Phibro's Performance Boost: Phibro Animal Health Corporation's earnings estimate has increased by 9.1% in the past 60 days, with a PEG ratio of 1.07, significantly lower than the industry average of 2.68, highlighting the company's competitive edge and growth potential in the animal health sector.
- Commercial Metals Growth Outlook: Commercial Metals Company has experienced a 21.3% increase in its current year earnings estimate over the last 60 days, with a PEG ratio of 0.39, showcasing strong growth potential in the steel and metals manufacturing industry, likely attracting more investor interest.
- Investment Opportunities: Zacks Investment Research anticipates the release of 10 top stock picks for 2026, with historical performance suggesting they could significantly outperform the S&P 500, prompting investors to keep an eye on these high-return opportunities.
See More
RenaissanceRe Holdings (RNR) Raises 2023 Earnings Estimate by 27.6%
- Earnings Estimate Increase: RenaissanceRe Holdings Ltd. has seen its 2023 earnings estimate raised by 27.6% over the past 60 days, indicating strong performance in the insurance and reinsurance sectors, which is expected to drive stock price appreciation and bolster investor confidence.
- Industry Competitiveness: The company's PEG ratio stands at 1.61, lower than the industry average of 1.81, highlighting its relatively high growth potential, which may attract more investor interest and enhance its market position.
- Growth Score: With a Growth Score of B, RenaissanceRe is recognized for its growth potential within the industry, likely appealing to investors seeking stable returns and further driving capital inflows.
- Market Opportunity: As demand for insurance and reinsurance rises, the upward revision of RenaissanceRe's earnings estimates may enable it to capture a larger share in a competitive market, facilitating sustainable growth.
See More
Zacks.com Spotlights Vertiv, RenaissanceRe, Ameren, Canadian Natural Resources, and FedEx
Market Overview: The U.S. economy is experiencing challenges such as persistent inflation and declining job growth, prompting the Federal Reserve to cut interest rates for the third time this year, complicating stock market interpretations for retail investors.
Sales Growth as a Metric: Focusing on sales growth rather than earnings is recommended for stock evaluation, as it provides a clearer picture of a company's business momentum and potential for future earnings improvement.
Highlighted Stocks: Five stocks with strong sales growth potential are identified: Vertiv Holdings Co (27.5% expected growth), RenaissanceRe Holdings Ltd (3.4%), Ameren Corp (17.7%), Canadian Natural Resources Ltd (5.9%), and FedEx Corp (4.6%).
Investment Tools: Zacks Investment Research offers the Research Wizard, a user-friendly stock picking and backtesting software, to help investors identify promising stocks based on sales growth and other metrics.
See More
RenaissanceRe Holdings (RNR.US) Officer Plans to Sell $4.43 Million in Common Stock via Form 144 Amendment
- Stock Sale Announcement: Officer Ross Curtis of Renaissance Re Holdings intends to sell 15,000 shares of its common stock.
- Market Value: The total market value of the shares being sold is approximately $4.43 million.
See More
RenaissanceRe Q4 Earnings Exceed Expectations
- Earnings Beat: RenaissanceRe reported a Q4 non-GAAP EPS of $13.34, surpassing expectations by $2.93, which reflects the company's strong profitability and boosts investor confidence.
- Significant Revenue Growth: The company achieved revenues of $2.97 billion in Q4, marking a 29.7% year-over-year increase and exceeding forecasts by $1.3 billion, indicating robust competitive positioning and business expansion capabilities.
- Undervalued Preferred Stocks: Market analysis suggests that RenaissanceRe's preferred stocks are undervalued, potentially offering investors a compelling opportunity, highlighting the company's advantages in capital structure.
- Positive Future Outlook: With ongoing growth in the insurance and reinsurance markets, analysts maintain an optimistic outlook for RenaissanceRe's future performance, which is expected to further enhance shareholder returns and market share.
See More
RenaissanceRe Q4 Earnings Announcement Scheduled
- Earnings Release Date: RenaissanceRe is set to announce its Q4 earnings on February 3rd after market close, with a consensus EPS estimate of $10.41, reflecting a 29.2% year-over-year growth, indicating sustained profitability.
- Revenue Expectations Decline: Despite the optimistic EPS outlook, the revenue estimate stands at $1.67 billion, representing a 27.1% year-over-year decline, highlighting potential challenges in the market environment and business fluctuations.
- Historical Performance: Over the past two years, RenaissanceRe has beaten EPS estimates 88% of the time and revenue estimates 63% of the time, demonstrating the company's reliability in earnings forecasts and market confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 14 upward revisions and 1 downward revision, while revenue estimates have had 1 upward revision with no downward adjustments, reflecting analysts' optimistic outlook on the company's future performance.
See More
RenaissanceRe, Phibro, and Commercial Metals Rated Strong with Notable Earnings Growth
- RenaissanceRe Earnings Surge: RenaissanceRe Holdings Ltd. has seen its current year earnings estimate rise by 27.4% over the last 60 days, indicating robust performance in the insurance and reinsurance sector, which is likely to drive stock price appreciation and bolster market confidence.
- Phibro's Performance Boost: Phibro Animal Health Corporation's earnings estimate has increased by 9.1% in the past 60 days, with a PEG ratio of 1.07, significantly lower than the industry average of 2.68, highlighting the company's competitive edge and growth potential in the animal health sector.
- Commercial Metals Growth Outlook: Commercial Metals Company has experienced a 21.3% increase in its current year earnings estimate over the last 60 days, with a PEG ratio of 0.39, showcasing strong growth potential in the steel and metals manufacturing industry, likely attracting more investor interest.
- Investment Opportunities: Zacks Investment Research anticipates the release of 10 top stock picks for 2026, with historical performance suggesting they could significantly outperform the S&P 500, prompting investors to keep an eye on these high-return opportunities.
See More
RenaissanceRe Holdings (RNR) Raises 2023 Earnings Estimate by 27.6%
- Earnings Estimate Increase: RenaissanceRe Holdings Ltd. has seen its 2023 earnings estimate raised by 27.6% over the past 60 days, indicating strong performance in the insurance and reinsurance sectors, which is expected to drive stock price appreciation and bolster investor confidence.
- Industry Competitiveness: The company's PEG ratio stands at 1.61, lower than the industry average of 1.81, highlighting its relatively high growth potential, which may attract more investor interest and enhance its market position.
- Growth Score: With a Growth Score of B, RenaissanceRe is recognized for its growth potential within the industry, likely appealing to investors seeking stable returns and further driving capital inflows.
- Market Opportunity: As demand for insurance and reinsurance rises, the upward revision of RenaissanceRe's earnings estimates may enable it to capture a larger share in a competitive market, facilitating sustainable growth.
See More
Zacks.com Spotlights Vertiv, RenaissanceRe, Ameren, Canadian Natural Resources, and FedEx
Market Overview: The U.S. economy is experiencing challenges such as persistent inflation and declining job growth, prompting the Federal Reserve to cut interest rates for the third time this year, complicating stock market interpretations for retail investors.
Sales Growth as a Metric: Focusing on sales growth rather than earnings is recommended for stock evaluation, as it provides a clearer picture of a company's business momentum and potential for future earnings improvement.
Highlighted Stocks: Five stocks with strong sales growth potential are identified: Vertiv Holdings Co (27.5% expected growth), RenaissanceRe Holdings Ltd (3.4%), Ameren Corp (17.7%), Canadian Natural Resources Ltd (5.9%), and FedEx Corp (4.6%).
Investment Tools: Zacks Investment Research offers the Research Wizard, a user-friendly stock picking and backtesting software, to help investors identify promising stocks based on sales growth and other metrics.
See More
